Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Tripalmitoleoylglycerol for the Treatment of Dermatitis.

NCT07366255 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.

NCT NCT07366255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07366255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Tripalmitoleoylglycerol for the Treatment of Dermatitis.
Lead sponsor
Shenzhen People's Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 10, 2026
Completion date
March 8, 2026
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pasi /scorad index, skin barrier to water loss